Examining the bleeding incidences associated with targeted therapies used in metastatic renal cell carcinoma.
Sign Up to like & getrecommendations! Published in 2017 at "Critical reviews in oncology/hematology"
DOI: 10.1016/j.critrevonc.2017.10.014
Abstract: A systematic review was conducted to illustrate the bleeding risks associated with targeted therapies used in the treatment of metastatic renal cell carcinoma (mRCC). Eligible studies included phase II, III, or IV clinical trials using… read more here.
Keywords: renal cell; therapies used; associated targeted; metastatic renal ... See more keywords
Assessment of bleeding incidences associated with rivaroxaban therapy in adults with solid tumors
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Oncology Pharmacy Practice"
DOI: 10.1177/1078155218765635
Abstract: Purpose Report bleeding incidences associated with rivaroxaban in adult patients with solid tumor malignancies requiring anticoagulation therapy. Methods This retrospective review was conducted at Indiana University Health, University Hospital and the Simon Cancer Center in… read more here.
Keywords: incidences associated; experienced bleeding; associated rivaroxaban; bleeding incidences ... See more keywords